GSK Bio
NEWS
Could GlaxoSmithKline’s industry-leading dividend be at risk?
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech.
Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college.
Another top executive at Glaxo is leaving the company as new CEO Emma Walmsley continues to shape the c-suite for her administration.
Merck released its third-quarter financial results today, and along with it a hint--just a hint--that there might be some M&A deals in the future.
Earlier this month, Pfizer’s chairman and CEO, Ian Read, said he was considering selling the company’s Consumer Healthcare business, or possibly spinning it off.
After four months of looking, Five Prime Therapeutics has found its new CEO.
JOBS
IN THE PRESS